Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-52 |
filingDate |
1997-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d09dcf2d692a0c4403899ffa5a27faa0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba69ecb9c45febbd7a337c71fc146a00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c735eab2d81a970a4c70640ce88b7a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34c34cce7094cb9cfa63812064603eef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77bde4927d04ed55e80d58791171c114 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42045de2cb6cab0528e57e1dc8ae8bc7 |
publicationDate |
1999-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
DE-19733439-A1 |
titleOfInvention |
New 6-endo-amino-3-azabicyclo (3.1.0) hexande, process for their preparation and their use for the preparation of quinolone and naphthyridinecarboxylic acid derivatives with improved properties |
abstract |
The invention relates to novel 3-azabicyclo[3.1.0]hexanes with a doubly protected amino group in position 6, and to a method for producing the same from chloramines or bicyclic N,O acetals or bicyclic nitriles. The two protective groups on the amino group in 6 and the group on N(3) can be specifically removed. The novel 3-azabicyclo[3.1.0]hexanes with a doubly protected amino group in position 6 are suitable for manufacturing pharmaceutical products, e.g. gyrase inhibitors, which can be modified by subsequently splitting off the protective groups. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0930297-A1 |
priorityDate |
1997-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |